Literature DB >> 18929545

Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes).

Laura M Harrison1, Gerald J Lahoste, David N Ruskin.   

Abstract

Rhes is one of several signaling molecules preferentially expressed in the striatum. This GTP-binding protein affects dopamine-mediated signaling and behavior. Denervating the striatum of its dopaminergic inputs in adulthood reduces rhes mRNA expression. Here we show that dopamine depletion in adult rats by 6-hydroxydopamine caused a significant decrease in striatal Rhes protein levels as measured by Western blotting. The role of dopamine input on rhes mRNA induction during ontogeny was also examined. Rhes mRNA was measured on postnatal days 4, 6, 8, 10, 15, and 24 with in situ hybridization to determine its normal ontogeny. Signal in striatum was detectable, but very low, on postnatal day 4 and increased gradually to peak levels at days 15 and 24. Outside of the striatum, rhes mRNA was expressed at high levels in hippocampus and cerebellum during the postnatal period. Hippocampal signal was initially highest in CA3 and dentate gyrus, but shifted to higher expression in CA1 by the late postnatal period. Several other nuclei showed low levels of rhes mRNA during ontogeny. Depletion of dopamine by 6-hydroxydopamine injection on postnatal day 4 did not affect the ontogenetic development of rhes mRNA, such that expression did not differ statistically in lesioned versus vehicle-treated animals tested in adulthood. These findings suggest that although dopamine input is not necessary for the ontogenetic development of rhes mRNA expression, changes in both rhes mRNA and Rhes protein are integral components of the response of the adult striatum to dopamine depletion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929545      PMCID: PMC2615551          DOI: 10.1016/j.brainres.2008.09.066

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  52 in total

1.  The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors.

Authors:  Pierfrancesco Vargiu; Ricardo De Abajo; Juan Antonio Garcia-Ranea; Alfonso Valencia; Pilar Santisteban; Piero Crespo; Juan Bernal
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

2.  Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study.

Authors:  P A Rao; P B Molinoff; J N Joyce
Journal:  Brain Res Dev Brain Res       Date:  1991-06-21

3.  Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases.

Authors:  Timothy E Graham; Eric R Prossnitz; Richard I Dorin
Journal:  J Biol Chem       Date:  2001-12-21       Impact factor: 5.157

4.  Activator of G-protein signaling 1 blocks GIRK channel activation by a G-protein-coupled receptor: apparent disruption of receptor signaling complexes.

Authors:  Aya Takesono; Mark W Nowak; Mary Cismowski; Emir Duzic; Stephen M Lanier
Journal:  J Biol Chem       Date:  2002-02-12       Impact factor: 5.157

5.  D2 dopamine receptor gene expression in the rat striatum during ontogeny: an in situ hybridization study.

Authors:  R Guennoun; B Bloch
Journal:  Brain Res Dev Brain Res       Date:  1991-05-20

6.  Thyroid hormone regulation of rhes, a novel Ras homolog gene expressed in the striatum.

Authors:  P Vargiu; B Morte; J Manzano; J Perez; R de Abajo; J Gregor Sutcliffe; J Bernal
Journal:  Brain Res Mol Brain Res       Date:  2001-10-19

7.  Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum.

Authors:  Douglas S Kim; Glenda J Froelick; Richard D Palmiter
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

8.  Dopamine-deficient mice are hypersensitive to dopamine receptor agonists.

Authors:  D S Kim; M S Szczypka; R D Palmiter
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

9.  Dopamine profoundly suppresses excitatory transmission in neonatal rat hippocampus via phosphatidylinositol-linked D1-like receptor.

Authors:  Y Noriyama; Y Ogawa; H Yoshino; M Yamashita; T Kishimoto
Journal:  Neuroscience       Date:  2006-01-10       Impact factor: 3.590

10.  Rhes is involved in striatal function.

Authors:  Daniela Spano; Igor Branchi; Annamaria Rosica; Maria Teresa Pirro; Antonio Riccio; Pratibha Mithbaokar; Andrea Affuso; Claudio Arra; Patrizia Campolongo; Daniela Terracciano; Vincenzo Macchia; Juan Bernal; Enrico Alleva; Roberto Di Lauro
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more
  11 in total

1.  Rhes and AGS1/Dexras1 affect signaling by dopamine D1 receptors through adenylyl cyclase.

Authors:  Laura M Harrison; Youe He
Journal:  J Neurosci Res       Date:  2011-03-03       Impact factor: 4.164

2.  Mice lacking rhes show altered morphine analgesia, tolerance, and dependence.

Authors:  Franklin A Lee; Brandon A Baiamonte; Daniela Spano; Gerald J Lahoste; R Denis Soignier; Laura M Harrison
Journal:  Neurosci Lett       Date:  2010-12-14       Impact factor: 3.046

Review 3.  Rhes: a GTP-binding protein integral to striatal physiology and pathology.

Authors:  Laura M Harrison
Journal:  Cell Mol Neurobiol       Date:  2012-03-27       Impact factor: 5.046

4.  Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum.

Authors:  L M Harrison; S H Muller; D Spano
Journal:  Neuroscience       Date:  2013-02-01       Impact factor: 3.590

5.  Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice.

Authors:  Daniela Vitucci; Annabella Di Giorgio; Francesco Napolitano; Barbara Pelosi; Giuseppe Blasi; Francesco Errico; Maria Teresa Attrotto; Barbara Gelao; Leonardo Fazio; Paolo Taurisano; Anna Di Maio; Valentina Marsili; Massimo Pasqualetti; Alessandro Bertolino; Alessandro Usiello
Journal:  Neuropsychopharmacology       Date:  2015-07-31       Impact factor: 7.853

6.  Post-translational modification biology of glutamate receptors and drug addiction.

Authors:  Li-Min Mao; Ming-Lei Guo; Dao-Zhong Jin; Eugene E Fibuch; Eun Sang Choe; John Q Wang
Journal:  Front Neuroanat       Date:  2011-03-17       Impact factor: 3.856

7.  Exploration of sex differences in Rhes effects in dopamine mediated behaviors.

Authors:  Gabriel C Quintero; Daniela Spano
Journal:  Neuropsychiatr Dis Treat       Date:  2011-11-17       Impact factor: 2.570

8.  Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.

Authors:  Francesco Napolitano; Emily Booth Warren; Sara Migliarini; Daniela Punzo; Francesco Errico; Qin Li; Marie-Laure Thiolat; Angelo Luigi Vescovi; Paolo Calabresi; Erwan Bezard; Micaela Morelli; Christine Konradi; Massimo Pasqualetti; Alessandro Usiello
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

9.  MicroRNA-101 inhibits the expression of Rhes, a striatal-enriched small G-protein, at the post-transcriptional level in vitro.

Authors:  Hideya Mizuno; Ayako Taketomi
Journal:  BMC Res Notes       Date:  2018-07-31

Review 10.  Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's Disease.

Authors:  Marcello Serra; Annalisa Pinna; Giulia Costa; Alessandro Usiello; Massimo Pasqualetti; Luigi Avallone; Micaela Morelli; Francesco Napolitano
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.